CORIXA CORP 4

4 · CORIXA CORP · Filed Jul 14, 2005

Insider Transaction Report

Form 4

Period: 2005-07-12

CORIXA CORPCRXA

GILLIS STEVEN

DirectorCEO

Transactions

Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−7,285→ 0 total
Exercise: $6.41From: 2005-07-12Exp: 2013-01-03→ Common Stock (7,285 underlying)
Exercise/Conversion
Common Stock
2005-07-12$3.95/sh+149,999$592,496→ 519,478 total
Award
Common Stock
2005-07-12$2.61/sh+160$418→ 369,639 total
Disposition to Issuer
Common Stock
2005-07-12$4.40/sh−369,639$1,626,412→ 0 total
Disposition to Issuer
Incentive Stock Option
2005-07-12−21,543→ 0 total
Exercise: $8.69From: 2005-07-12Exp: 2009-01-29→ Common Stock (21,543 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−64,525→ 0 total
Exercise: $6.04From: 2005-07-12Exp: 2013-12-31→ Common Stock (64,525 underlying)
Exercise/Conversion
Incentive Stock Option
2005-07-12−1→ 0 total
Exercise: $3.95From: 2005-07-12Exp: 2014-12-15→ Common Stock (1 underlying)
Disposition to Issuer
Incentive Stock Option
2005-07-12−9,274→ 0 total
Exercise: $9.50From: 2005-07-12Exp: 2008-01-16→ Common Stock (9,274 underlying)
Disposition to Issuer
Incentive Stock Option
2005-07-12−5,769→ 0 total
Exercise: $13.45From: 2005-07-12Exp: 2011-10-26→ Common Stock (5,769 underlying)
Disposition to Issuer
Incentive Stock Option
2005-07-12−25,475→ 0 total
Exercise: $6.04From: 2005-07-12Exp: 2013-12-31→ Common Stock (25,475 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−10,938→ 0 total
Exercise: $17.00From: 2005-07-12Exp: 2009-12-31→ Common Stock (10,938 underlying)
Disposition to Issuer
Common Stock
2005-07-12$4.40/sh+149,999$659,996→ 369,479 total
Disposition to Issuer
Incentive Stock Option
2005-07-12−12,750→ 0 total
Exercise: $9.50From: 2005-07-12Exp: 2008-01-16→ Common Stock (12,750 underlying)
Exercise/Conversion
Common Stock
2005-07-12$0.99/sh+17,171$16,999→ 369,479 total
Disposition to Issuer
Incentive Stock Option
2005-07-12−7,715→ 0 total
Exercise: $6.41From: 2005-07-12Exp: 2013-01-03→ Common Stock (7,715 underlying)
Disposition to Issuer
Incentive Stock Option
2005-07-12−5,250→ 0 total
Exercise: $15.07From: 2005-07-12Exp: 2011-12-31→ Common Stock (5,250 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−138,487→ 0 total
Exercise: $5.70From: 2005-07-12Exp: 2012-06-14→ Common Stock (138,487 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−219→ 0 total
Exercise: $15.07From: 2005-07-12Exp: 2011-12-31→ Common Stock (219 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−15,726→ 0 total
Exercise: $9.50From: 2005-07-12Exp: 2008-01-16→ Common Stock (15,726 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−5,031→ 0 total
Exercise: $15.07From: 2005-07-12Exp: 2011-12-31→ Common Stock (5,031 underlying)
Award
Common Stock
2004-12-31$3.09/sh+808$2,500→ 348,964 total
Award
Common Stock
2005-06-30$2.61/sh+3,343$8,724→ 352,307 total
Exercise/Conversion
Common Stock
2005-07-12$3.95/sh+1$4→ 352,308 total
Exercise/Conversion
Incentive Stock Option
2005-07-12−17,171→ 0 total
Exercise: $0.99From: 2005-07-12Exp: 2007-02-27→ Common Stock (17,171 underlying)
Disposition to Issuer
Incentive Stock Option
2005-07-12−11,513→ 0 total
Exercise: $5.70From: 2005-07-12Exp: 2012-06-14→ Common Stock (11,513 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−109,231→ 0 total
Exercise: $13.45From: 2005-07-12Exp: 2011-10-26→ Common Stock (109,231 underlying)
Disposition to Issuer
Incentive Stock Option
2005-07-12−4,062→ 0 total
Exercise: $17.00From: 2005-07-12Exp: 2009-12-31→ Common Stock (4,062 underlying)
Exercise/Conversion
Non-Qualified Stock Option
2005-07-12−149,999→ 0 total
Exercise: $3.95From: 2005-07-12Exp: 2014-12-15→ Common Stock (149,999 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2005-07-12−51,957→ 0 total
Exercise: $8.69From: 2005-07-12Exp: 2009-01-29→ Common Stock (51,957 underlying)

Footnotes (2)

[F1]Pursuant to the Merger Agreement with GSK, these options were canceled at the time of the Merger. Net cash consideration was received.
[F2]Pursuant to the Merger Agreement with GSK, the underlying option was canceled at the time of the Merger. No net cash consideration was received.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION